These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12477412)
1. New technology platforms in the development of vaccines for the future. Glück R; Metcalfe IC Vaccine; 2002 Dec; 20 Suppl 5():B10-6. PubMed ID: 12477412 [TBL] [Abstract][Full Text] [Related]
2. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems. Glück R; Metcalfe IC Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327 [TBL] [Abstract][Full Text] [Related]
3. Inflexal V a trivalent virosome subunit influenza vaccine: production. Mischler R; Metcalfe IC Vaccine; 2002 Dec; 20 Suppl 5():B17-23. PubMed ID: 12477413 [TBL] [Abstract][Full Text] [Related]
4. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Hunziker IP; Zurbriggen R; Glueck R; Engler OB; Reichen J; Dai WJ; Pichler WJ; Cerny A Mol Immunol; 2001 Dec; 38(6):475-84. PubMed ID: 11741697 [TBL] [Abstract][Full Text] [Related]
5. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV). Glück R; Wälti E Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236 [TBL] [Abstract][Full Text] [Related]
6. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system. Cryz SJ; Glück R Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278 [TBL] [Abstract][Full Text] [Related]
7. Vaccines for the prevention of respiratory viral infections: problems and current status. Olszewska W; Helson R; Openshaw PJ Expert Opin Investig Drugs; 2004 Jun; 13(6):681-9. PubMed ID: 15174954 [TBL] [Abstract][Full Text] [Related]
8. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
9. Vaccines in the prevention of viral pneumonia. Betts RF Semin Respir Infect; 1995 Dec; 10(4):282-7. PubMed ID: 8668856 [TBL] [Abstract][Full Text] [Related]
10. Immunization against respiratory virus infections. Hobson D Mod Trends Immunol; 1967; 2():53-85. PubMed ID: 4298139 [No Abstract] [Full Text] [Related]
11. Vaccination against acute respiratory virus infections and measles in man. Osterhaus AD; de Vries P Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542 [TBL] [Abstract][Full Text] [Related]
12. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge. Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863 [TBL] [Abstract][Full Text] [Related]
14. Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections. Hurwitz JL Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S126-8. PubMed ID: 18820573 [TBL] [Abstract][Full Text] [Related]
15. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells. Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436 [TBL] [Abstract][Full Text] [Related]